Point72 (DIFC)’s IGM Biosciences IGMS Stock Holding History

Point72 (DIFC)’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-388	Closed	-$435	–	1505
2025 Q2	$435	Sell	388 -456	-54%	-$557	﹤0.01%	1470
2025 Q1	$971	Buy	844 +147	+21%	+$273	﹤0.01%	1581
2024 Q4	$4.26K	Buy	+697	New	+$8.28K	﹤0.01%	1398

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Point72 (DIFC)'s IGMS Position: Q3 2025 in Review

Point72 (DIFC) sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 388 shares — an estimated $435 sold.

Point72 (DIFC) first reported a position in IGMS in Q4 2024 and held it in 3 quarters. The position peaked at $4.26K in Q4 2024. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Point72 (DIFC) reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Point72 (DIFC) sold 388 IGM Biosciences shares in Q3 2025, an estimated $435.
Point72 (DIFC) first reported a position in IGM Biosciences in Q4 2024 and held it in 3 quarters.
Point72 (DIFC)'s IGM Biosciences position peaked at $4.26K in Q4 2024.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.